These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11769302)

  • 1. Finding undiagnosed type 2 diabetes: is it worth the effort?
    Engelgau MM; Narayan KM
    Eff Clin Pract; 2001; 4(6):281-3. PubMed ID: 11769302
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the price of life and why doesn't it increase at the rate of inflation?
    Ubel PA; Hirth RA; Chernew ME; Fendrick AM
    Arch Intern Med; 2003 Jul; 163(14):1637-41. PubMed ID: 12885677
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
    Colagiuri S; Walker AE
    Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How frequently should patients with type 2 diabetes mellitus be screened for retinopathy?
    Murphy C; Newton W
    J Fam Pract; 2000 May; 49(5):395-6. PubMed ID: 10836765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Opportunistic screening for diabetes in primary health care. Life style changes can prevent diabetes mellitus among individuals at risk].
    Hagström B
    Lakartidningen; 2002 Apr; 99(16):1852. PubMed ID: 12043490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance and the practical implications from a clinical perspective.
    Rahme K
    Int J Clin Pract; 2008 Jul; 62(7):988-9. PubMed ID: 18564271
    [No Abstract]   [Full Text] [Related]  

  • 10. Should we screen for type 2 diabetes: Yes.
    Khunti K; Davies M
    BMJ; 2012 Jul; 345():e4514. PubMed ID: 22777029
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost effectiveness of screening of all newly recruited employees for diabetes at a tertiary care hospital.
    Ali NS; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2007; 19(2):23-5. PubMed ID: 18183713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New criteria for the detection, diagnosis, and classification of diabetes mellitus.
    Wood ME
    Nurse Pract Forum; 1998 Jun; 9(2):38-41. PubMed ID: 9752115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for diabetes: yes! but how?].
    Hauner H
    Dtsch Med Wochenschr; 2006 Oct; 131(40):2207. PubMed ID: 17021987
    [No Abstract]   [Full Text] [Related]  

  • 17. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes in children and adolescents. Literature shows screening is overlooked.
    Cox D; Polvado KJ
    Adv Nurse Pract; 2008 Nov; 16(11):43-5. PubMed ID: 19999055
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mass screening for reduced glucose tolerance].
    von Eyben FE
    Ugeskr Laeger; 2002 Sep; 164(36):4197-8; author reply 4198. PubMed ID: 12362840
    [No Abstract]   [Full Text] [Related]  

  • 20. Can a screening programme for diabetes be applied to another population?
    Glümer C; Borch-Johnsen K; Colagiuri S
    Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.